Serum neurofilament heavy chains as a biomarker of neuronal damage in multiple sclerosis relapse
Introduction. One of the newest methods that could facilitate the diagnosis and treatment of multiple sclerosis is the measurement of neurofilament levels in the blood and spinal fluid. Neurofilament chains can be found not only in multiple sclerosis but also in other neurodegenerative diseases. La...
Saved in:
Main Authors: | P. Beliaziūnas, R. Godelienė, L. Malcienė, V. Natkevičius, V. Gintauskienė, B. Šitkauskienė, M. Malciūtė |
---|---|
Format: | Article |
Language: | English |
Published: |
Vilnius University Press
2021-03-01
|
Series: | Neurologijos seminarai |
Subjects: | |
Online Access: | https://www.journals.vu.lt/neurologijos_seminarai/article/view/27704 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The role of neurofilament light chain in the context of neurological disorders
by: V. Taluntienė, et al.
Published: (2020-12-01) -
Functional and Cognitive Impairment in Patients with Relapsing–Remitting Multiple Sclerosis: Cognitive Tests and Plasma Neurofilament Light Chain Levels
by: Elina Polunosika, et al.
Published: (2025-01-01) -
Prognostic Value of Cerebrospinal Fluid and Serum Neurofilament Light Chain in Amyotrophic Lateral Sclerosis: A Correlation Study
by: Siqi Dong, et al.
Published: (2025-01-01) -
Comorbidity in in patients with relapsing-remitting multiple sclerosis
by: O.V. Somilo, et al.
Published: (2024-10-01) -
Shared prognostic information in amyotrophic lateral sclerosis – systematic assessment of the patients’ perception of neurofilament light chain and the ALS functional rating scale
by: Lukas Maximilian Möhwald, et al.
Published: (2025-02-01)